An Observational Study Providing 12 Months of Safety Follow-Up from First Exposure to HP802-247 in Subjects Who Participated in Study 802-247-09-032(EU) [EXTENSION OF 700237977]

Trial Profile

An Observational Study Providing 12 Months of Safety Follow-Up from First Exposure to HP802-247 in Subjects Who Participated in Study 802-247-09-032(EU) [EXTENSION OF 700237977]

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs HP 802247 (Primary)
  • Indications Leg ulcer; Varicose ulcer
  • Focus Adverse reactions; Registrational
  • Sponsors Smith & Nephew
  • Most Recent Events

    • 02 Mar 2016 Status changed from active, no longer recruiting to completed, according to European Clinical Trials Database record.
    • 18 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 31 Oct 2013 New source identified and integrated: ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top